APA (7th ed.) Citation

Chatzis, O., Blanchard-Rohner, G., Mondoulet, L., Pelletier, B., De Gea-Hominal, A., Roux, M., . . . Siegrist, C. (2021). Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: A phase I, randomized, double-blind, placebo-controlled trial. Clinical Microbiology & Infection, 27(6), 878. https://doi.org/10.1016/j.cmi.2020.08.033

Chicago Style (17th ed.) Citation

Chatzis, O., et al. "Safety and Immunogenicity of the Epicutaneous Reactivation of Pertussis Toxin Immunity in Healthy Adults: A Phase I, Randomized, Double-blind, Placebo-controlled Trial." Clinical Microbiology & Infection 27, no. 6 (2021): 878. https://doi.org/10.1016/j.cmi.2020.08.033.

MLA (9th ed.) Citation

Chatzis, O., et al. "Safety and Immunogenicity of the Epicutaneous Reactivation of Pertussis Toxin Immunity in Healthy Adults: A Phase I, Randomized, Double-blind, Placebo-controlled Trial." Clinical Microbiology & Infection, vol. 27, no. 6, 2021, p. 878, https://doi.org/10.1016/j.cmi.2020.08.033.